IDiyas

For the Inventor, By the Inventor

Boston, MA, United States of America

X4 Pharmaceuticals, Inc.


USPTO Granted Patents = 16



Trademarks = 10

Forward Citations = 51

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Renato T Skerlj (5 out of 28 patents)

silverMedal Elyse Marie Josee Bourque (5 out of 23 patents)

bronzeMedal Robert D Arbeit (5 out of 5 patents)

4.  Paula Marie Ragan (4 out of 4 patents)

5.  Karel Marie Joseph Brands (3 out of 3 patents)

6.  Sarah Cohen (2 out of 2 patents)

7.  E Lynne Kelley (2 out of 2 patents)

8.  Michael B Atkins (1 out of 1 patent)

9.  James W Mier (1 out of 1 patent)

10.  David McDermott (1 out of 1 patent)

11.  Kieran James Crowley (1 out of 2 patents)

12.  Karel Marie Joseph Brands (1 out of 1 patent)

13.  Eszter Nagy (41 patents)

14.  Zoltán Magyarics (4 patents)

15.  Irina Mirkina (7 patents)


16 patents:

1. 12377090 - Methods for treating neutropenia (2025-08-05),
2. 12285424 - Methods for treating neutropenia (2025-04-29),
3. 12115156 - Compositions of CXCR4 inhibitors and methods of preparation and use (2024-10-15),
4. 11780837 - CXCR4 inhibitors and uses thereof (2023-10-10),
5. 11672793 - Compositions of CXCR4 inhibitors and methods of preparation and use (2023-06-13),
6. 11357742 - Methods for treating cancer (2022-06-14),
7. 11337969 - Methods for treating cancer (2022-05-24),
8. 11332470 - CXCR4 inhibitors and uses thereof (2022-05-17),
9. 11306088 - CXCR4 inhibitors and uses thereof (2022-04-19),
10. 11219621 - Methods for treating immunodeficiency disease (2022-01-11),
11. 11045461 - Compositions of CXCR4 inhibitors and methods of preparation and use (2021-06-29),
12. 10988465 - CXCR4 inhibitors and uses thereof (2021-04-27),
13. 10953003 - Methods for treating cancer (2021-03-23),
14. 10759796 - CXCR4 inhibitors and uses thereof (2020-09-01),
15. 10610527 - Methods for treating immunodeficiency disease (2020-04-07),
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of rare diseases. The company is leveraging its expertise in chemokine biology to discover and develop small molecule inhibitors of chemokine receptors that play a key role in immune system modulation. X4 Pharmaceuticals is dedicated to bringing innovative treatments to patients with rare diseases that have limited or no treatment options.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#136 in Boston, MA

#1,160 in Massachusetts

#19,271 in US

#36,634 in the World

...
Boston, MA, United States of America

X4 Pharmaceuticals, Inc.

Forward Citations = 51

40 inventors:

goldMedal Renato T Skerlj (5 out of 28 patents)

silverMedal Elyse Marie Josee Bourque (5 out of 23 patents)

bronzeMedal Robert D Arbeit (5 out of 5 patents)

4.  Paula Marie Ragan (4 out of 4 patents)

5.  Karel Marie Joseph Brands (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…